Devices, systems, and methods for training pelvic floor muscles

An intravaginal device comprising:

• a) a substantially ring-shaped form having an outer edge configured to contact the vaginal wall and an internal diameter sized to substantially circumferentially surround a cervix or a vaginal cuff;
• and
• b) a tether comprising at least one sensor that is capable of detecting an upward lifting movement of a pelvic floor muscle of an individual.

A method of treating, or inhibiting or reducing the development or progression of, a pelvic floor disorder in an individual comprising inserting the intravaginal device of any one of claim 1 to 59 or 99 into the vagina of the individual and monitoring the engagement of, or relaxation of, a pelvic floor muscle of the individual with the intravaginal device, wherein the treatment reduces the frequency of occurrence and/or severity of at least one symptom of a pelvic floor disorder.

A method of treating, or inhibiting or reducing the development or progression of, a pelvic floor disorder or a disease or condition of the vaginal tissues or female urogenital system in an individual comprising inserting the intravaginal device of any one of claim 1 to 59 or 99 into the vagina of the individual, wherein the intravaginal device comprises at least one pharmaceutical agent useful in treating a PFD or the symptoms thereof.

A method of calibrating an intravaginal device for treating, or inhibiting or reducing the development or progression of, a pelvic floor disorder in an individual comprising:

• (a) inserting the intravaginal device of any one of claim 1 to 59 or 99 into the vagina of the individual and monitoring the engagement of, or relaxation of, a pelvic floor muscle of the individual with the intravaginal device over a calibration period;
• and
• (b) using the data collected over the calibration period to calculate a baseline score for at least one performance metric of the engagement of, or relaxation of, a pelvic floor muscle of the individual and/or at least one characteristic of the pelvic floor disorder of the subject.

The method of claim 89 or 103, wherein the at least one performance metric of the engagement of, or relaxation of, a pelvic floor muscle of the individual and/or the at least one characteristic of the pelvic floor disorder is selected from the group consisting of the maximum number of pelvic floor lifts and/or the maximum number of pelvic floor relaxations performed, the maximum strength of a pelvic floor lift and/or a pelvic floor relaxation performed, and muscle quality, muscle strength, and/or vaginal pH.

A kit for treating or reducing the progression of a pelvic floor disorder in an individual, comprising the intravaginal device of any one of claim 1 to 59 or 99-102 or the system of any one of claims 91 to 93, and instructions for use thereof.

The intravaginal device of 111, wherein the detachable cable is configured to assist in the removal of the intravaginal device.